{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:58:16Z","timestamp":1740128296751,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurovirol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1080\/13550280600724319","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T15:06:43Z","timestamp":1151075203000},"page":"140-145","source":"Crossref","is-referenced-by-count":24,"title":["Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1\u2013infected brains"],"prefix":"10.1007","volume":"12","author":[{"given":"Janelle M","family":"Silvers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Y","family":"Aksenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina V","family":"Aksenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Beckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Olton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles F","family":"Mactutus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemarie M","family":"Booze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Adamson, D and Dawson, T and Zink, M and Clements, J and Dawson, V. (1996) Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis Mol Med<\/i>, 2, pp. 417 - 428. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00002","unstructured":"Aksenov, M and Hasselrot, U and Wu, G and Nath, A and Anderson, C and Mactutus, C and Booze, R. (2003) Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum Brain Res<\/i>, 987, pp. 1 - 9. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00003","unstructured":"Arendt, G. (2005) Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART) Fortschr Neurol Psychiatr<\/i>, 73, pp. 577 - 586. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Berger, J and Arendt, G. (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems Psychopharmacol<\/i>, 14, pp. 214 - 221. [CSA]<\/A>","DOI":"10.1177\/026988110001400304"},{"key":"E00005","unstructured":"Blanchard-Fillion, B and Souza, J and Friel, T and Jiang, G and Vrana, K and Sharov, V and (2001) Nitration and inactivation of tyrosine hydroxylase by peroxynitrite J Biol Chem<\/i>, 279, pp. 46017 - 46023. [CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00006","unstructured":"Blennow, K and Wallin, A and Ekman, R. (1994) Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders? J Neural Transm Park Dis Dement Sect<\/i>, 8, pp. 183 - 91. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00007","unstructured":"Boven, L and Gomes, L and Hery, C and Gray, F and Verhoef, J and Portegies, P and (1999) Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection J Immunol<\/i>, 162, pp. 4319 - 4327. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Butterfield, D and Stadtman, E. (1997) Protein oxidation processes in aging brain Adv Cell Aging Gerontol<\/i>, 2, pp. 161 - 191. [CSA]<\/A>","DOI":"10.1016\/S1566-3124(08)60057-7"},{"key":"E00009","unstructured":"Dewhurst, S and Gelbard, H and Fine, S. (1996) Neuropathogenesis of AIDS Mol Med Today<\/i>, 2, pp. 16 - 23. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00010","unstructured":"Ding, M and Haglid, K and Hamberger, A. (2000) Quantitative immunochemistry on neuronal loss, reactive gliosis and BBB damage in cortex\/striatum and hippocampus\/amygdale after systemic kainic acid administration Neurochem Int<\/i>, 36, pp. 313 - 318. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00011","unstructured":"Epstein, L. (1998) HIV neuropathogenesis and therapeutic strategies Acta Paediatr Jpn<\/i>, 40, pp. 107 - 111. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00012","unstructured":"Hudson, L and Liu, J and Nath, A and Jones, M and Raghavan, R and Narayan, O and (2000) Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues J NeuroVirol<\/i>, 6, pp. 145 - 155. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Itoh, K and Mehraein, P and Weis, S. (2000) Neuronal damage of the substantia nigra in HIV-1 infected brains Acta Neuropathol (Berl)<\/i>, 99, pp. 376 - 384. [CSA]<\/A>[CROSSREF]<\/A>","DOI":"10.1007\/s004010051139"},{"key":"E00014","unstructured":"Jones, M and Bell, J and Nath, A. (2000) Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia AIDS<\/i>, 14, pp. 2709 - 2713. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Koutsiliery, E and Sopper, S and Scheller, C and ter Meulen, V and Riederer, P. (2002) Involvement of dopamine in the progression of AIDS dementia complex J Neural Transm<\/i>, 109, pp. 399 - 410. [CSA]<\/A>[CROSSREF]<\/A>","DOI":"10.1007\/s007020200032"},{"key":"E00016","unstructured":"Kumer, S and Vrana, K. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression J Neurochem<\/i>, 67, pp. 443 - 462. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00017","unstructured":"Li, L and Chen, N and Ramamoorthy, S and Chi, L and Cui, X and Wang, L and (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter J Biol Chem<\/i>, 279, pp. 21012 - 21020. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Manji, H and Miller, R. (2004) Neurology of HIV infection J Neurol Neurosurg Psychiatry<\/i>, 75, pp. 29 - 35. [CSA]<\/A>[CROSSREF]<\/A>","DOI":"10.1136\/jnnp.2003.034348"},{"key":"E00019","unstructured":"Mash, D and Pablo, J and Ouyang, Q and Hearn, W and Izenwasser, S. (2002) Dopamine transport function is elevated in cocaine users J Neurochem<\/i>, 81, pp. 292 - 300. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Miller, G and Staley, J and Heilman, C and Perez, J and Mash, D and Rye, D and (1997) Immunochemical analysis of dopamine transporter protein in Parkinson's disease Ann Neurology<\/i>, 41, pp. 530 - 539. [CSA]<\/A>[CROSSREF]<\/A>","DOI":"10.1002\/ana.410410417"},{"key":"E00021","unstructured":"Nath, A and Anderson, C and Jones, M and Maragos, W and Booze, R and Mactutus, C and (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia J Psychopharmacol<\/i>, 14, pp. 222 - 227. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00022","unstructured":"Nath, A and Hauser, K and Wojna, V and Booze, R and Maragos, W and Prendergast, M and (2002) Molecular basis for interactions of HIV and drugs of abuse J Acquir Immune Defic Syndr<\/i>, 31, pp. S62 - S69. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00023","unstructured":"Navia, B and Cho, E and Petito, C and Price, R. (1986) The AIDS dementia complex. II. Neuropathology Ann Neurol<\/i>, 19, pp. 525 - 535. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Reyes, M and Faraldi, F and Senseng, C and Flowers, C and Fariello, R. (1991) Nigral degeneration in acquired immune deficiency syndrome (AIDS) Acta Neuropathol (Berl)<\/i>, 82, pp. 39 - 44. [CSA]<\/A>[CROSSREF]<\/A>","DOI":"10.1007\/BF00310921"},{"key":"E00025","unstructured":"Saito, Y and Sharer, L and Epstein, L and Michaels, J and Mintz, M and Louder, M and (1994) Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues Neurology<\/i>, 44, pp. 474 - 481. [INFOTRIEVE]<\/A>[CSA]<\/A>"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Wallace, D and Dodson, S and Nath, A and Booze, R. (2005) Estrogen attenuates gp120- and tat(1-72)-induced oxidative stress and prevents loss of dopamine transporter function Synapse<\/i>, 59, pp. 51 - 60. [CSA]<\/A>[CROSSREF]<\/A>","DOI":"10.1002\/syn.20214"},{"key":"E00027","unstructured":"Wang, J and Chang, L and Volkow, N and Telang, F and Logan, J and Ernst, T and (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients Brain<\/i>, 127, pp. 2452 - 2458. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"},{"key":"E00028","unstructured":"Zauli, G and Secchierro, P and Rodella, L and Gibellini, D and Mirandola, P and Mazzoni, M and (2000) HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells J Biol Chem<\/i>, 275, pp. 4159 - 4165. [INFOTRIEVE]<\/A>[CSA]<\/A>[CROSSREF]<\/A>"}],"container-title":["Journal of Neurovirology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:43:22Z","timestamp":1555670602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1080\/13550280600724319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1080\/13550280600724319"],"URL":"https:\/\/doi.org\/10.1080\/13550280600724319","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}